Literature DB >> 6999029

Reactivity of microhemagglutination, fluorescent treponemal antibody absorption, and venereal disease research laboratory tests in primary syphilis.

J D Dyckman, S Storms, T W Huber.   

Abstract

Seroreactivity in 130 cases of primary syphilis was 91.5% by fluorescent treponemal antibody absorption test, 82.3% by microhemagglutination (MHA-TP test), and 68.5% by the Venereal Disease Reseach Laboratory (VDRL) test. The MHA TP test generally became reactive earlier than the VDRL test and confirmed all reactive and most weakly reactive VDRL results.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6999029      PMCID： PMC273654          DOI： 10.1128/jcm.12.4.629-630.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

1.  TPHA test. Experience at the Clinic of Dermatology, University of Milan.

Authors:  E Alessi; L Scioccati
Journal:  Br J Vener Dis       Date:  1978-06

2.  Evaluation of a quantitative automated micro-hemagglutination assay for antibodies to Treponema pallidum.

Authors:  L C Logan; P M Cox
Journal:  Am J Clin Pathol       Date:  1970-02       Impact factor: 2.493

3.  The microhemagglutination assay for Treponema pallidum antibodies (MHA-TP), a new treponemal test for syphilis: where does it fit?

Authors:  A H Rudolph
Journal:  J Am Vener Dis Assoc       Date:  1976-09

4.  Hemagglutination tests for syphilis antibody.

Authors:  H W Jaffe; S A Larsen; O G Jones; P E Dans
Journal:  Am J Clin Pathol       Date:  1978-08       Impact factor: 2.493
  4 in total
  8 in total

1.  Primary and secondary syphilis, 20 years' experience. 3: Diagnosis, treatment, and follow up.

Authors:  J Anderson; A Mindel; S J Tovey; P Williams
Journal:  Genitourin Med       Date:  1989-08

Review 2.  Syphilis in pregnancy.

Authors:  M Genç; W J Ledger
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

3.  Reactivity of microhemagglutination, fluorescent treponemal antibody absorption, Venereal Disease Research Laboratory, and rapid plasma reagin tests in primary syphilis.

Authors:  T W Huber; S Storms; P Young; L E Phillips; T E Rogers; D G Moore; R P Williams
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

4.  Serospecificity of a cloned protease-resistant Treponema pallidum--specific antigen expressed in Escherichia coli.

Authors:  S R Coates; P J Sheridan; D S Hansen; W J Laird; H A Erlich
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

5.  Evaluation of a Treponema pallidum enzyme immunoassay as a screening test for syphilis.

Authors:  N E Hooper; D C Malloy; S Passen
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

6.  Modification of the system of screening for antisyphilis antibodies in a blood transfusion centre, featuring a miniaturisation of the Treponema pallidum haemagglutination assay.

Authors:  A Puckett; G Pratt
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

7.  Specificity, sensitivity, and reproducibility among the fluorescent treponemal antibody-absorption test, the microhemagglutination assay for Treponema pallidum antibodies, and the hemagglutination treponemal test for syphilis.

Authors:  S A Larsen; E A Hambie; D E Pettit; M W Perryman; S J Kraus
Journal:  J Clin Microbiol       Date:  1981-10       Impact factor: 5.948

8.  Syphilis Laboratory Guidelines: Performance Characteristics of Nontreponemal Antibody Tests.

Authors:  Susan Tuddenham; Samantha S Katz; Khalil G Ghanem
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.